Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.583440
Title: Characterisation of a novel transglutaminase, TGase 6, and determination of its expression pattern
Author: Thomas, Helen Ann
Awarding Body: Cardiff University
Current Institution: Cardiff University
Date of Award: 2004
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Transglutaminases represent a family of enzymes capable of stabilising protein assemblies by y-glutamyl-e-lysine crosslinks. These enzymes catalyse a calcium-dependent transferase reaction between the y-carboxamide group of a peptide-bound glutamine residue and primary amines, most commonly the e-amino group of lysine residues. Eight different transglutaminase gene products have previously been characterised in man, and found to have specialised in the crosslinking of proteins in different biological processes. Identification of a gene cluster on mouse chromosome 2 and analysis of the homologous chromosomal sequences on human chromosome 20ql 1 revealed the presence of a novel gene, TGM6, located upstream from the gene encoding transglutaminase 3. A corresponding gene product, transglutaminase 6 could be identified in a small lung carcinoma cell line, called H69, demonstrating that this was a functional gene. The gene product in human and mouse was subsequently characterised by determining its primary structure and deduced amino acid sequence. This revealed the existence of several splice variants. Analysis of its expression on a RNA and protein level using in situ hybridisation and immunohistochemistry revealed that transglutaminase 6 is expressed predominantly in the central nervous system but also in a number of other tissues, for example, in the epidermis of skin, in the developing vertebrae and other long bones, and in the retinal cells of the eye. Expression was also detected in the brain, particularly in the neuronal cells of the cerebral cortex and the Purkinje cells of the cerebellum. The expression in the cerebral cortex correlated with neurogenesis during development. Transglutaminase activity has been implicated in the formation of aberrant protein complexes in the central nervous system resulting in nerve cell degeneration, for example, in Alzheimer's disease and Huntington's disease. Based on its expression pattern, transglutaminase 6 is a possible candidate to generate the underlying transglutaminase-related pathological changes.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.583440  DOI: Not available
Share: